Joshua J. Souchek, Ph.D.
Affiliations: | 2013 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Oncology, Pharmacy, BiochemistryGoogle:
"Joshua Souchek"Parents
Sign in to add mentorSurinder K. Batra | grad student | 2013 | University of Nebraska Medical Center | |
(Optimization of Therapeutics against Lethal Pancreatic Cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
File N, Carmicheal J, Krasnoslobodtsev AV, et al. (2022) Substituent Effects Impact Surface Charge and Aggregation of Thiophenol-Labeled Gold Nanoparticles for SERS Biosensors. Biosensors. 12 |
Japp NC, Souchek JJ, Sasson AR, et al. (2021) Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection. Journal of Immunology Research. 2021: 9942605 |
Souchek JJ, Wojtynek NE, Payne WM, et al. (2018) Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft. Acta Biomaterialia |
Qi B, Crawford AJ, Wojtynek NE, et al. (2018) Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomedicine : Nanotechnology, Biology, and Medicine |
Gunda V, Souchek JJ, Abrego J, et al. (2017) MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Souchek JJ, Davis AL, Hill TK, et al. (2017) Combination treatment with orlistat-containing nanoparticles and taxanes is synergistic and enhances microtubule stability in taxane-resistant prostate cancer cells. Molecular Cancer Therapeutics |
Seshacharyulu P, Baine MJ, Souchek JJ, et al. (2017) Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochimica Et Biophysica Acta |
Gunda V, Souchek J, Abrego J, et al. (2017) Abstract 459: Targeting MUC1 mediated nucleotide metabolism sensitizes pancreatic tumors to radiation therapy Cancer Research. 77: 459-459 |
Hill TK, Kelkar SS, Wojtynek NE, et al. (2016) Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery. Theranostics. 6: 2314-2328 |
Shukla SK, Dasgupta A, Mehla K, et al. (2015) Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget |